Wearable sensor

Information

  • Patent Grant
  • D1083640
  • Patent Number
    D1,083,640
  • Date Filed
    Tuesday, May 16, 2023
    2 years ago
  • Date Issued
    Tuesday, July 15, 2025
    5 months ago
  • Inventors
    • Morelock; David Michael (Escondido, CA, US)
  • Original Assignees
  • Examiners
    • Davis; Antoine Duval
    Agents
    • Cooley LLP
  • US Classifications
    Field of Search
    • US
    • D10 78
    • D10 81
    • D24 108
    • D24 134
    • D24 186
    • D24 187
    • D24 216
    • CPC
    • A61B5/1473
    • A61B5/155
    • A61B5/157
    • A61B5/14503
    • A61B5/1451
    • A61B5/14532
    • A61B5/6832
    • A61B5/6848
    • A61B2560/0412
    • A61B5/6801
    • A61B5/6802
    • A61B5/6813
    • A61B5/6814
    • A61B5/6815
    • A61B5/6816
    • A61B5/6817
    • A61B5/6818
    • A61B5/6819
    • A61B5/6822
    • A61B5/6823
    • A61B5/6824
    • A61B5/6825
    • A61B5/6826
    • A61B5/6828
    • A61B5/6829
    • G01N33/66
    • G04B47/065
    • G04B47/066
    • G04B47/068
  • International Classifications
    • 1004
    • Term of Grant
      15Years
Abstract
Description


FIG. 1 is a front perspective view of a wearable sensor showing the new design;



FIG. 2 is a front view thereof;



FIG. 3 is a rear view thereof;



FIG. 4 is a left side view thereof;



FIG. 5 is a right side view thereof;



FIG. 6 is a top plan view thereof;



FIG. 7 is a bottom plan view thereof;



FIG. 8 is a front perspective view of a wearable sensor showing the new design;



FIG. 9 is a front view thereof;



FIG. 10 is a rear view thereof;



FIG. 11 is a left side view thereof;



FIG. 12 is a right side view thereof;



FIG. 13 is a top plan view thereof;



FIG. 14 is a bottom plan view thereof;



FIG. 15 is a front perspective view of a wearable sensor showing the new design;



FIG. 16 is a front view thereof;



FIG. 17 is a rear view thereof;



FIG. 18 is a left side view thereof;



FIG. 19 is a right side view thereof;



FIG. 20 is a top plan view thereof;



FIG. 21 is a bottom plan view thereof;



FIG. 22 is a front perspective view of a wearable sensor showing the new design;



FIG. 23 is a front view thereof;



FIG. 24 is a rear view thereof;



FIG. 25 is a left side view thereof;



FIG. 26 is a right side view thereof;



FIG. 27 is a top plan view thereof;



FIG. 28 is a bottom plan view thereof;



FIG. 29 is a front perspective view of a wearable sensor showing the new design;



FIG. 30 is a front view thereof;



FIG. 31 is a rear view thereof;



FIG. 32 is a left side view thereof;



FIG. 33 is a right side view thereof;



FIG. 34 is a top plan view thereof;



FIG. 35 is a bottom plan view thereof;



FIG. 36 is a front perspective view of a wearable sensor showing the new design;



FIG. 37 is a front view thereof;



FIG. 38 is a rear view thereof;



FIG. 39 is a left side view thereof;



FIG. 40 is a right side view thereof;



FIG. 41 is a top plan view thereof; and,



FIG. 42 is a bottom plan view thereof.


The broken lines are for the purpose of illustrating portions of the article and form no part of the claimed design.


Claims
  • The ornamental design for a wearable sensor, as shown and described.
US Referenced Citations (276)
Number Name Date Kind
3964482 Gerstel et al. Jun 1976 A
4305401 Reissmueller et al. Dec 1981 A
4323996 Ganter Apr 1982 A
4407295 Steuer et al. Oct 1983 A
5131390 Sakaguchi et al. Jul 1992 A
5279543 Glikfeld et al. Jan 1994 A
5286364 Yacynych et al. Feb 1994 A
5540828 Yacynych Jul 1996 A
5730714 Guy et al. Mar 1998 A
5766132 Yasukawa et al. Jun 1998 A
6036055 Mogadam et al. Mar 2000 A
6139718 Kurnik et al. Oct 2000 A
6269053 Kawata et al. Jul 2001 B1
6284126 Kurnik et al. Sep 2001 B1
6413396 Yang et al. Jul 2002 B1
6471903 Sherman et al. Oct 2002 B2
D474197 Nguyen May 2003 S
6603987 Whitson Aug 2003 B2
6814845 Wilson et al. Nov 2004 B2
6862466 Ackerman Mar 2005 B2
6908453 Fleming et al. Jun 2005 B2
7097776 Govinda Raju Aug 2006 B2
7132054 Kravitz et al. Nov 2006 B1
7262068 Roy et al. Aug 2007 B2
7310544 Brister et al. Dec 2007 B2
7343188 Sohrab Mar 2008 B2
7344499 Prausnitz et al. Mar 2008 B1
D567249 Gunn et al. Apr 2008 S
7429333 Chiou et al. Sep 2008 B2
7456112 Lee Nov 2008 B2
7493232 Surina Feb 2009 B1
D625733 Anzures Oct 2010 S
8022292 Arianpour et al. Sep 2011 B2
8060318 Vering et al. Nov 2011 B2
D651613 Ouilhet Jan 2012 S
8088321 Ferguson et al. Jan 2012 B2
8094009 Allen et al. Jan 2012 B2
8125331 Allen et al. Feb 2012 B2
8130095 Allen et al. Mar 2012 B2
8280475 Brister et al. Oct 2012 B2
8284046 Allen et al. Oct 2012 B2
8574165 Marsh Nov 2013 B2
D699251 Rao et al. Feb 2014 S
D701964 Yoneta et al. Apr 2014 S
8750955 Brister et al. Jun 2014 B2
8798799 Deo et al. Aug 2014 B2
8909543 Tropper et al. Dec 2014 B2
D722697 Moon et al. Feb 2015 S
9041730 Johnson et al. May 2015 B2
9055901 Brister et al. Jun 2015 B2
9107623 Brauker et al. Aug 2015 B2
D744529 Guzmán et al. Dec 2015 S
D745046 Shin et al. Dec 2015 S
D750786 Davies et al. Mar 2016 S
D757000 Lagomarsino et al. May 2016 S
D760277 Park Jun 2016 S
D763894 Lamparelli Aug 2016 S
D771824 Minoli Nov 2016 S
D773529 Cabrera, Jr. et al. Dec 2016 S
D776285 Dinger Jan 2017 S
9551698 Huys et al. Jan 2017 B2
D778952 Kim et al. Feb 2017 S
D789391 Cabrera, Jr. et al. Jun 2017 S
D794801 Newhouse et al. Aug 2017 S
9717843 Grucela et al. Aug 2017 B2
9737247 Wang et al. Aug 2017 B2
9743870 Wang et al. Aug 2017 B2
D803250 Lee et al. Nov 2017 S
D806706 Kim et al. Jan 2018 S
D810952 Hsu Feb 2018 S
D813877 Hough et al. Mar 2018 S
D815289 Evers et al. Apr 2018 S
D816229 Frick et al. Apr 2018 S
9933387 McCanna et al. Apr 2018 B1
D820988 Pushpala et al. Jun 2018 S
D821571 Stonecipher et al. Jun 2018 S
10004435 Larvenz et al. Jun 2018 B2
10029043 Grucela et al. Jul 2018 B2
10092207 Windmiller Oct 2018 B1
D832870 Hu Nov 2018 S
D833023 Maletic Nov 2018 S
10136846 Wang et al. Nov 2018 B2
D842996 Frick et al. Mar 2019 S
D845289 Chuang et al. Apr 2019 S
10251565 Chan et al. Apr 2019 B2
D850626 Gardner et al. Jun 2019 S
10321859 Wynbrandt et al. Jun 2019 B1
D853382 Haigh Jul 2019 S
10362973 Hernandez-Rosas et al. Jul 2019 B2
D864985 Kim et al. Oct 2019 S
D864993 Kim et al. Oct 2019 S
D867911 Alabdin Nov 2019 S
D870291 Barry et al. Dec 2019 S
10492708 Windmiller Dec 2019 B1
D873294 Anzures et al. Jan 2020 S
D875106 Winton et al. Feb 2020 S
D875254 Cooke et al. Feb 2020 S
D882432 Yee et al. Apr 2020 S
D888731 Momchilov et al. Jun 2020 S
10765369 Antonio et al. Sep 2020 B2
D898924 Hinds et al. Oct 2020 S
D903877 Pace et al. Dec 2020 S
11039767 Hayter Jun 2021 B2
11045142 Windmiller et al. Jun 2021 B1
D928150 Maruyama et al. Aug 2021 S
11087868 Budiman Aug 2021 B2
11102306 Mensinger et al. Aug 2021 B2
D929990 Maruyama et al. Sep 2021 S
D931467 Golda et al. Sep 2021 S
11141116 Cabrera, Jr. et al. Oct 2021 B2
11150145 Nekoomaram et al. Oct 2021 B2
11154253 Cabrera, Jr. et al. Oct 2021 B2
11182332 Anderson et al. Nov 2021 B2
11197626 Koehler et al. Dec 2021 B2
11205511 Hayter et al. Dec 2021 B2
11207025 Trapero et al. Dec 2021 B1
11272890 McGarraugh Mar 2022 B2
11305906 Grucela et al. Apr 2022 B2
D951972 Vincent et al. May 2022 S
11317867 Garai et al. May 2022 B2
D954744 Feitosa et al. Jun 2022 S
11357430 Pushpala et al. Jun 2022 B2
11373347 Kamath et al. Jun 2022 B2
D957438 Hayter et al. Jul 2022 S
D958184 Page Jul 2022 S
D958817 Mensinger et al. Jul 2022 S
11389088 Desborough et al. Jul 2022 B2
D960895 Mensinger Aug 2022 S
D960913 Kiikkala et al. Aug 2022 S
D962446 Bernstein et al. Aug 2022 S
11406331 Budiman Aug 2022 B2
11406818 Windmiller Aug 2022 B2
11437141 Mensinger et al. Sep 2022 B2
11446108 Larson et al. Sep 2022 B2
D967128 Kumar et al. Oct 2022 S
D967136 Kumar et al. Oct 2022 S
11464459 Sjolund et al. Oct 2022 B2
11475988 Burkart et al. Oct 2022 B1
11478194 Windmiller et al. Oct 2022 B2
11497422 Koehler et al. Nov 2022 B2
11507530 Anderson et al. Nov 2022 B2
11517222 Pushpala et al. Dec 2022 B2
11534089 Taub et al. Dec 2022 B2
D977116 Gennaco et al. Jan 2023 S
11547799 Zhong et al. Jan 2023 B2
D978178 Lamb et al. Feb 2023 S
D978357 Zysk et al. Feb 2023 S
11576600 Lee et al. Feb 2023 B2
11654270 Mansfield, III et al. May 2023 B2
11660392 Kamen et al. May 2023 B2
D988160 Morelock Jun 2023 S
11672965 Mansfield et al. Jun 2023 B2
D996999 Morelock Aug 2023 S
D1004105 Zysk et al. Nov 2023 S
D1006265 Quitter et al. Nov 2023 S
D1006266 Quitter et al. Nov 2023 S
D1010133 Yee et al. Jan 2024 S
D1012292 Armstrong et al. Jan 2024 S
D1012744 Morelock Jan 2024 S
11857344 Windmiller et al. Jan 2024 B2
11872055 Tangney et al. Jan 2024 B2
D1013544 Morelock Feb 2024 S
11904127 Mansfield et al. Feb 2024 B2
11963796 Windmiller et al. Apr 2024 B1
11986614 Mansfield et al. May 2024 B2
12011294 Campbell et al. Jun 2024 B2
D1033641 Morelock Jul 2024 S
D1035004 Morelock Jul 2024 S
D1035670 Vanderhill et al. Jul 2024 S
D1038794 Morelock Aug 2024 S
D1040171 Chen et al. Aug 2024 S
12070313 Fuchs et al. Aug 2024 B2
12109032 Windmiller et al. Oct 2024 B1
D1051745 Morelock Nov 2024 S
D1057153 Morelock Jan 2025 S
20030225360 Eppstein et al. Dec 2003 A1
20060015061 Kuo et al. Jan 2006 A1
20070170054 Wilsey Jul 2007 A2
20070213044 Steingart et al. Sep 2007 A1
20090088652 Tremblay Apr 2009 A1
20090143761 Cantor et al. Jun 2009 A1
20090259118 Feldman et al. Oct 2009 A1
20100056873 Allen et al. Mar 2010 A1
20100286803 Tillotson et al. Nov 2010 A1
20120323097 Chowdhury Dec 2012 A9
20130065257 Wang et al. Mar 2013 A1
20130144131 Wang et al. Jun 2013 A1
20140259652 Pushpala et al. Sep 2014 A1
20140275897 Pushpala et al. Sep 2014 A1
20140336487 Wang et al. Nov 2014 A1
20150335272 Natale et al. Nov 2015 A1
20150351689 Adams et al. Dec 2015 A1
20170003766 Budiman Jan 2017 A1
20170055851 Al-Ali Mar 2017 A1
20170215774 Koehler et al. Aug 2017 A1
20170290532 Antonio et al. Oct 2017 A1
20180042559 Cabrera, Jr. et al. Feb 2018 A1
20180116572 Simpson et al. May 2018 A1
20180249937 Wiese et al. Sep 2018 A1
20180295897 Donohoe et al. Oct 2018 A1
20190095602 Setlak et al. Mar 2019 A1
20190125223 Wang et al. May 2019 A1
20190133638 Ii et al. May 2019 A1
20190167167 Mitchell et al. Jun 2019 A1
20190246914 Constantin et al. Aug 2019 A1
20190246973 Constantin et al. Aug 2019 A1
20190274603 Ringemann Sep 2019 A1
20190307376 Hernandez-Rosas et al. Oct 2019 A1
20190309433 Sattayasamitsathit et al. Oct 2019 A1
20200085341 Windmiller Mar 2020 A1
20200101286 Windmiller et al. Apr 2020 A1
20200146598 Mayou et al. May 2020 A1
20200214566 Allen et al. Jul 2020 A1
20200245914 Bhavaraju et al. Aug 2020 A1
20200254240 Windmiller et al. Aug 2020 A1
20200275870 Bhavaraju et al. Sep 2020 A1
20200297997 Windmiller et al. Sep 2020 A1
20200337615 Larvenz et al. Oct 2020 A1
20210113132 Bhagat et al. Apr 2021 A1
20210161436 Troncelliti et al. Jun 2021 A1
20210169384 Taub et al. Jun 2021 A1
20210187286 Windmiller et al. Jun 2021 A1
20210196162 Halac et al. Jul 2021 A1
20210236057 Pushpala et al. Aug 2021 A1
20210282672 Kumar et al. Sep 2021 A1
20210321914 Brister et al. Oct 2021 A1
20210335499 Simpson et al. Oct 2021 A1
20210345894 Maceachern et al. Nov 2021 A1
20210361199 Kumar Nov 2021 A1
20210378601 Kumar et al. Dec 2021 A1
20210393201 Morelock et al. Dec 2021 A1
20220000399 Hayter et al. Jan 2022 A1
20220000432 Cabrera, Jr. et al. Jan 2022 A1
20220031209 Windmiller et al. Feb 2022 A1
20220031244 Windmiller et al. Feb 2022 A1
20220057868 Budiman Feb 2022 A1
20220080678 Cole et al. Mar 2022 A1
20220087610 Pushpala et al. Mar 2022 A1
20220095930 Li et al. Mar 2022 A1
20220101995 Johnson et al. Mar 2022 A1
20220142524 Harper et al. May 2022 A1
20220142589 Lee May 2022 A1
20220175278 Campbell et al. Jun 2022 A1
20220194644 Grucela et al. Jun 2022 A1
20220202319 Crawford et al. Jun 2022 A1
20220202320 Diener et al. Jun 2022 A1
20220216735 Yan et al. Jul 2022 A1
20220265224 Hauptman et al. Aug 2022 A1
20220283042 Nekoomaram et al. Sep 2022 A1
20220292746 Kamath et al. Sep 2022 A1
20220336100 Chiu et al. Oct 2022 A1
20220361825 Kang Nov 2022 A1
20220370011 Windmiller et al. Nov 2022 A1
20220392643 Mensinger et al. Dec 2022 A1
20230005588 Sokolovskyy et al. Jan 2023 A1
20230074798 Tangney et al. Mar 2023 A1
20230094419 Mansfield, III et al. Mar 2023 A1
20230099617 Mansfield, III et al. Mar 2023 A1
20230137258 Windmiller May 2023 A1
20230190147 Campbell et al. Jun 2023 A1
20230256220 Mansfield, III Aug 2023 A1
20230301552 Mallires et al. Sep 2023 A1
20230310823 Mansfield, III Oct 2023 A1
20230414102 Allen et al. Dec 2023 A1
20240008777 Fuchs Jan 2024 A1
20240081740 Windmiller et al. Mar 2024 A1
20240164719 Campbell et al. May 2024 A1
20240252115 Tangney et al. Aug 2024 A1
20240315614 Campbell et al. Sep 2024 A1
20240341636 Yang et al. Oct 2024 A1
20240366125 Alonso-Soski et al. Nov 2024 A1
20240382157 Windmiller et al. Nov 2024 A1
20240408366 Mansfield et al. Dec 2024 A1
20240423526 Windmiller et al. Dec 2024 A1
20250000395 Brister et al. Jan 2025 A1
20250049397 Campbell et al. Feb 2025 A1
Foreign Referenced Citations (40)
Number Date Country
717520 Dec 2021 CH
305781317 May 2020 CN
306169676 Nov 2020 CN
306260908 Jan 2021 CN
306893408 Oct 2021 CN
307293994 Apr 2022 CN
307384488 Jun 2022 CN
307672333 Nov 2022 CN
308050427 May 2023 CN
001371280-0001 Jun 2013 EM
3871602 Sep 2021 EP
3042872 Dec 2020 FR
06192168 Feb 2022 GB
1721016 Jul 2022 JP
2013502603 Nov 2014 KR
WO-2009034313 Mar 2009 WO
WO-2009034313 Mar 2009 WO
WO-2009064164 May 2009 WO
WO-2009064164 May 2009 WO
WO-2010107913 Sep 2010 WO
WO-2010120364 Oct 2010 WO
WO-2010120364 Oct 2010 WO
WO-2012020332 Feb 2012 WO
WO-2012020332 Feb 2012 WO
WO-2013058879 Apr 2013 WO
WO-2013058879 Apr 2013 WO
WO-2020073060 Apr 2020 WO
WO-D214300002 May 2021 WO
WO-2021148596 Jul 2021 WO
WO-2022044017 Mar 2022 WO
WO-2022031792 Apr 2022 WO
WO-2022044018 Apr 2022 WO
WO-2022266443 Dec 2022 WO
WO-2023055755 Apr 2023 WO
WO-2023064877 Apr 2023 WO
WO-2023133468 Jul 2023 WO
WO-2023229662 Nov 2023 WO
WO-2024010827 Jan 2024 WO
WO-2024163950 Aug 2024 WO
WO-2024238798 Nov 2024 WO
Non-Patent Literature Citations (101)
Entry
Abbot press release (2020). “New late-breaking data show use of Abbott's Freestyle® Libre System significantly reduces HBA1C levels in people with type 2 diabetes using insulin or not,” 3 pages.
Al Hayek et al., “Patient Satisfaction and Clinical Efficacy of Novel Blood Glucose Meters Featuring Color Range Indicators in Patients With Type 2 Diabetes: A Prospective Study” Cureus Oct. 27, 2020; 12(10):e11195. 8 pages. doi:10.7759/cureus.11195.
Allen et al., “Continuous glucose monitoring counseling improves physical activity behaviors of individuals with type 2 diabetes: A randomized clinical trial” Diabetes Res Clin Pract. Jun. 2008 80(3): 371-379. doi:10.1016/j.diabres.2008.01.006.
American Diabetes Association® Press Release (2020). “American Diabetes Association® Applauds policymakers' Focus on Addressing High Costs of Insulin for Seven Million Americans,” 4 pages.
Bantle, J.P. et al. (1997). “Glucose measurement in patients with diabetes mellitus with dermal interstitial fluid,” J. Lab. Clin. Med. 130:436-441.
Barrett et al., “Risk for Newly Diagnosed Diabetes 30 Days After SARS-CoV-2 Infection Among Persons Aged 18 Years—United States, Mar. 1, 2020-Jun. 28, 2021” MMWR Morb Mortal Wkly Rep. Jan. 14, 2022; 71(2):59-65. doi:10.15585/mmwr.mm7102e2.
Beckles, G.L. et al. (2016). “Disparities in the prevalence of diagnosed diabetes—United States, 1999-2002 and 2011-2014,” MMWR 65:1265-1269.
Biolinq, Inc. (2019). The Intelligent Continuous Glucose Monitoring System, 5 total pages.
Cao, J. et al. (2017). “Validation of capillary blood analysis and capillary testing mode on the epoc Point of Care system,” Pract. Lab. Med. 9:24-27.
Castle, J.R. et al. (2012). “The accuracy benefit of multiple amperometric glucose sensors in people with type 1 diabetes,” Diabetes Care 35:706-710.
Centers for Disease Control, “National Diabetes Statistics Report 2020 Estimates of Diabetes and Its Burden in the United States” (2020) 32 pages.
Dexcom (2020). Analyst Day Presentation, 19 total pages.
Dexcom (2020). Analyst Day Presentation, 27 total pages.
Diabetes Care (2021). “7. Diabetes Technology: Standards of Medical Care in Diabetes—2021,” Diabetes Care 44(Supplement 1):S85-S99.
Dunkin et al., “Scarring occurs at a critical depth of skin injury: precise measurement in a graduated dermal scratch in human volunteers” Plast Reconstr Surg. May 2007; 119(6):1722-1732. doi: 10.1097/01.prs.0000258829.07399.f0.
Ehrhardt et al., “Behavior Modification in Prediabetes and Diabetes: Potential Use of Real-Time Continuous Glucose Monitoring” Journal of Diabetes Science and Technology Mar. 2019; 13(2):271-275.
Ehrhardt et al., “Continuous Glucose Monitoring as a Behavior Modification Tool” Clin Diabetes. Apr. 2020; 38(2):126-131. doi: 10.2337/cd19-0037.
Ehrhardt et al., “The Effect of Real-Time Continuous Glucose Monitoring on Glycemic Control in Patients with Type 2 Diabetes Mellitus” Journal of Diabetes Science and Technology May 2011; 5(3):668-675.
Fang, M. et al. (2021). “Trends in Diabetes Treatment and Control in U.S. Adults, 1999-2018,” N. Engl. Med. 384:2219-2228.
Fonda et al., “The Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (RT-CGM) in Type 2 Diabetes” Journal of Diabetes Science and Technology (2016) 10(4):898-904.
French, D.P. et al. (2008). “Original Article: Psychological Care Self-monitoring of blood glucose changed non-insulin-treated Type 2 diabetes patients' beliefs about diabetes and self-monitoring in a randomized trial,” Diav. Med. 25:1218-1228.
Grady, M. et al. (2017). “Examining the Impact of a Novel Blood Glucose Monitor with Color Range Indicator on Decision-Making in Patients With Type 1 and Type 2 Diabetes and its Association With Patient Numeracy Level,” JMIR Diabetes 2:e24. 11 pages.
Grady, M. et al. (2018). “Use of Blood Glucose Meters Featuring Color Range Indicators Improves Glycemic Control in Patients with Diabetes in Comparison to Blood Glucose Meters Without Color (Accents Study),” J. Diab. Sci. Tech. 12:1211-1219.
Groenendaal, W. et al. (2008). “Modeling Glucose and Water Dynamics in Human Skin,” Diab. Tech. Therap. 10:283-293.
Han et al., “The End of the Road for the YSI 2300 Analyzer: Where Do We Go Now?” Journal of Diabetes Science and Technology (2020) 14(3):595-600.
Han et al., “The YSI 2300 Analyzer Replacement Meeting Report” Journal of Diabetes Science and Technology (2020) 14(3):679-686.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2008). “Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes,” N. Engl. Med. 359:1464-1476.
Karter, A.J. et al. (2021). “Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes,” JAMA 325:2273-2284.
Martens, T. et al. (2021). “Effect of Continuous Glucose Monitoring on Glycemic Control in Patients with Type 2 Diabetes Treated with Basal Insulin A Randomized Clinical Trial,” JAMA 325:2262-2272.
McClatchey, P.M. et al. (2019). “Fibrotic Encapsulation Is the Dominant Source of Continuous Glucose Monitor Delays,” Diabetes 68:1892-1901.
Neerken, S. et al. (2004). “Characterization of age-related effects in human skin: A comparative study that applies confocal laser scanning microscopy and optical coherence tomography,” J. Biomed. Optics 9:274-281.
Non-Final Office Action mailed on Nov. 14, 2019, for U.S. Appl. No. 29/650,794, filed Jun. 8, 2018, 10 pages.
Notice of Allowance mailed on Dec. 18, 2019, for U.S. Appl. No. 29/650,794, filed Jun. 8, 2018, 7 pages.
Notice of Allowance mailed on Sep. 29, 2022, for U.S. Appl. No. 29/774,399, filed Mar. 16, 2021, 7 pages.
Notice of Allowance mailed on Jan. 25, 2023, for U.S. Appl. No. 29/774,399, filed Mar. 16, 2021, 11 pages.
Notice of Allowance mailed on Mar. 1, 2023, for U.S. Appl. No. 29/815,797, filed Nov. 16, 2021, 10 pages.
Notice of Allowance mailed on May 17, 2023, for U.S. Appl. No. 29/836,984, filed Apr. 29, 2022, 7 pages.
Notice of Allowance mailed on May 31, 2023, for U.S. Appl. No. 29/838,870, filed May 16, 2022, 7 pages.
Notice of Allowance mailed on Jun. 14, 2023, for U.S. Appl. No. 29/815,797, filed Nov. 16, 2021, 9 pages.
Polonsky, W.H. et al. (2011). “A survey of blood glucose monitoring in patients with type 2 diabetes: Are recommendations from health care professionals being followed?” Curr. Med. Res. & Opinion 27:31-37.
Rigla, M. et al. (2018). “Human Subcutaneous Tissue Response to Glucose Sensors: Macrophages Accumulation Impact on Sensor Accuracy,” Diabetes Technology & Therapeutics 20:296-302.
Sharifi et al., “Redundancy in Glucose Sensing: Enhanced Accuracy and Reliability of an Electrochemical Redundant Sensor for Continuous Glucose Monitoring” Journal of Diabetes Science and Technology (2016) 10(3):669-678.
Sheikh, Z. et al. (2015). “Macrophages, Foreign Body Giant Cells and Their Response to Implantable Biomaterials,” Materials 8:5671-5701.
Shi, T. et al. (2016). “Modeling and Measurement of Correlation between Blood and Interstitial Glucose Changes,” J. Diab. Res. Volume 2016, 9 pages.
Turner et al., “Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)” The Lancet Sep. 1998; 352(9131):837-853.
Vigersky et al., “Short- and Long-Term Effects of Real-Time Continuous Glucose Monitoring in Patients with Type 2 Diabetes” Diabetes Care Jan. 2012; 35:32-38.
Wolicki et al., “Epidemiology and Prevention of Vaccine-Preventable Diseases: Chapter 6: Vaccine Administration” Centers for Disease Control and Prevention (2021) 17 pages.
World Health Organization, “Diabetes”, Sep. 16, 2022, 5 pages.
Young et al., “Glucose Self-monitoring in Non-Insulin-Treated Patients With Type 2 Diabetes in Primary Care Settings: A Randomized Trial” JAMA Intern Med. Jul. 2017; 177(7):920-929.
Notice of Allowance mailed on Nov. 22, 2023, for U.S. Appl. No. 29/838,870, filed May 16, 2022, 7 pages.
Notice of Allowance mailed on Nov. 29, 2023, for U.S. Appl. No. 29/836,984, filed Apr. 29, 2022, 7 pages.
Abbott, Abbott's Freestyle® Libre 3 System Receives CE Mark, Published on: Sep. 28, 2020, PRNewswire.com, Retrieved from Internet: https://www.prnewswire.com/news-releases/abbotts-freestyle-libre-3-system-receives-ce-mark--features-worlds-smallest-thinnest-sensor-with-best-in-class-performance-at-the-same-low-cost-for -people-with-diabetes-301138719.html, 2 pages.
AiDEX, www.appadvice.com, retrieved online Sep. 4, 2024, posted online Nov. 9, 2022 URL:https://appadvice.com/app/wellion-aidex-sensor-mmol-I/6444144767. 1 page.
American Diabetes Association, “Diabetes and Emotional Health: A Practical Guide for Health Professionals Supporting Adults with Type 1 and Type 2 Diabetes” U.S. Edition (2021), 214 pages.
American Diabetes Association Professional Practice Committee, “6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes-2024” Diabetes Care Jan. 1, 2024; 47(Suppl 1):S111-S125.
American Diabetes Association Professional Practice Committee, “7. Diabetes Technology: Standards of Medical Care in Diabetes—2022” Diabetes Care Jan. 1, 2022; 45(Suppl 1):S97-S112.
Battelino et al., “Continuous glucose monitoring and metrics for clinical trials: an international consensus statement” Lancet Diabetes Endocrinol (2023) 11:42-57.
Biolinq, “Biolinq Announces Results from First-in-Man Clinical Studies Showing Feasibility of a Novel, Minimally Invasive Approach to Continuous Glucose Monitoring in the Dermis” Published on: Jun. 15, 2020, PRNewswire.com, Retrieved from Internet https://www.prnewswire.com/news-releases/biolinq-announces-results-from-first-in-man-clinical-studies-showing-feasibility-of-a-novel-minimally-invasive-approach-to-continuous-glucose-monitoring-in-the-dermis-301076992. html, 3 pages.
Blue Circle, www.instagram.com, By bluecirclediabetesfoundation, retrieved Sep. 4, 2024, posted online Jan. 12, 2020 URL:https://www.instagram.com/p/B7OINIHBIAD/?utm_source=ig_embed&utm_campaign=loading. 1 page.
Centers for Disease Control, “National Diabetes Statistics Report” May 2024, 16 pages.
Clutter et al., “Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man” J Clin Invest. (1980) 66(1):94-101.
Czupryniak et al., “Ambulatory Glucose Profile (AGP) Report in Daily Care of Patients with Diabetes: Practical Tips and Recommendations” Diabetes Ther (2022) 13:811-821.
Delve, Dexcom G6, Published in: 2019, Designdirectory.com, Retrieved from Internet: https://www.designdirectory.com/delve/Dexcom-G6?AspxAutoDetectCookieSupport=1 (Year: 2019), 3 pages.
Dexcom, www.diabetesstrong.com, By Christel Oerum, MS, retrieved online Sep. 4, 2024, posted online Apr. 20, 2020 URL:http://web.archive.org/web/20200420123603/https://diabetesstrong.com/dexcom-cgm-trend-arrows/. 1 page.
Diabetes Control and Complications Trial Research Group, “The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus” N Engl J Med Sep. 30, 1993; 329(14):977-986.
Diabetes.co.uk, “FDA approves new CGM the Abbott FreeStyle Libre Pro System” Published on: Sep. 29, 2016, diabetes.co.uk, Retrieved from Internet: https://www.diabetes.co.uk/news/2016/sep/fda-approves-new-cgm-the-abbott-freestyle-libre-pro-system-90611033.html (Year: 2016), 2 pages.
Donnelly et al., “Microneedle Arrays Allow Lower Microbial Penetration Than Hypodermic Needles In Vitro” Pharmaceutical Research (2009) 26(11):2513-2522.
Elsayed et al., “2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes—2023” Diabetes Care Jan. 1, 2023; 46(Suppl 1):S19-S40.
Fayfman et al., “Management of Hyperglycemic Crises: Diabetic ketoacidosis and hyperglycemic hyperosmolar state” Med Clin North Am. May 2017; 101(3):587-606.
Garg et al., “Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes”, Published on: May 31, 2022, Diabetes Technology & Therapeutics, Retrieved from Internet: https://www.liebertpub.com/doi/10.1089/dia.2022.0011 (Year: 2022), 2 pages.
Ghimire et al., “Ketoacidosis” StatPearls Publishing, Jan. 2024, NCBI Bookshelf, 8 pages.
Heinemann, “Interferences With CGM Systems: Practical Relevance?” Journal of Diabetes Science and Technology (2022) vol. 16(2) 271-274.
Henry et al. “Microfabricated microneedles: a novel approach to transdermal drug delivery.” Journal of pharmaceutical sciences. Aug. 1, 1998;87(8):922-925.
Idrus, “Medtronic integrates CGM, Fitbit data into mobile app” Published on: Dec. 19, 2016, Fierce Biotech.com, Retrieved from Internet : https://www.fiercebiotech.com/medical-devices/medtronic-integrates-cgm-fitbit-data-into-mobile-app (Year: 2016), 1 page.
Jina, A et al. (2014). “Design, development, and evaluation of a novel microneedle array-based continuous glucose monitor,” J. Diabetes Sci. Technol. 8:483-487.
Maahs et al., “Effect of Acetaminophen on CGM Glucose in an Outpatient Setting” Diabetes Care (2015) 38:e158-e159.
Mendes-Soares et al., “Assessment of a Personalized Approach to Predicting Postprandial Glycemic Responses to Food Among Individuals Without Diabetes” JAMA Network Open Feb. 1, 2019; 2(2):e188102. 13 pages.
Miller et al., “Hypoglycemia in patients with type 2 diabetes mellitus” Arch Intern Med Jul. 9, 2001; 161(13):1653-1659.
Newton et al., “Diabetic ketoacidosis in type 1 and type 2 diabetes mellitus: clinical and biochemical differences” Arch Intern Med Sep. 27, 2004; 164(17):1925-1931.
Nguyen et al., “Human studies with microneedles for evaluation of their efficacy and safety” Expert Opinion on Drug Delivery (2018) 15:3, 235-245.
Non-Final Office Action for U.S. Appl. No. 29/885,802 mailed Sep. 19, 2024, 10 pages.
Non-Final Office Action for U.S. Appl. No. 29/890,886 dated Mar. 28, 2024, 11 pages.
Notice of Allowance for U.S. Appl. No. 29/871,863 dated Feb. 26, 2024, 10 pages.
Notice of Allowance for U.S. Appl. No. 29/885,801 mailed Nov. 22, 2024, 10 pages.
Notice of Allowance for U.S. Appl. No. 29/890,886 mailed Jul. 15, 2024, 7 pages.
Notice of Allowance for U.S. Appl. No. 29/919,992 dated Mar. 28, 2024, 8 pages.
Ohashi et al., “Analgesic Effect of Acetaminophen: A Review of Known and Novel Mechanisms of Action” Front Pharmacol. Nov. 30, 2020;11:580289, 6 pages.
Prausnitz, “Engineering Microneedle Patches for Vaccination and Drug Delivery to Skin” Annu. Rev. Chem. Biomol. Eng. (2017) 8:177-200.
PRNewswire L'Oreal Unveils Prototype First-Ever Wearable Microfluidic Sensor, posted Jan. 6, 2019[online], [retrieved Jul. 2, 2024]. Retrieved from internet,https://www.prnewswire.com/news-releases/loreal-unveils-prototype-of-first-ever-wearable-microfluidic-sensor-to-measure-skin-ph-levels-300773342.html (Year: 2019), 11 pages.
Roche Diabetes Care, Roche Diabetes Carey Senseonics anuncian un acuerdo de distribuci6n para el sistema Eversense® CGM, Published on: May 26, 2016, PRNewswire.com, Retrieved from Internet: https://www.prnewswire.com/news-releases/roche-diabetes-care-y-senseonics-anuncian-un-acuerdo-de-distribucion-para-el-sistema-eversense-cgm-580978821.html, 1 page.
Round Navigation, www.pngtree.com, By 588ku, retrieved Sep. 4, 2024, posted online Jun. 18, 2018 URL:https://pngtree.com/freepng/round-navigation-icon_4752591.html. 1 page.
Samant et al., “Mechanisms of sampling interstitial fluid from skin using a microneedle patch,” Proc. Natl Acad. Sci. U.S.A. (2018) 115(8):4583-4588.
Segel et al., “Hypoglycemia-associated autonomic failure in advanced type 2 diabetes” Diabetes Mar. 2002; 51(3):724-733.
Shivers et al., “Turn it off !: diabetes device alarm fatigue considerations for the present and the future” J Diabetes Sci Technol May 1, 2013; 7(3):789-794.
Springer Link Microneedle—Based Sensor Systems for Real-Time Continuous Transdermal Monitoring of Analytes in Body Fluids, posted May 11, 2019 [online], [retrieved Jul. 2, 2024]. Retrieved from internet, https://link.springer.com/chapter/10.1007/978-3-030-17971-7_26 (Year: 2019), 23 pages.
Tanenbaum et al., “Diabetes Device Use in Adults With Type 1 Diabetes: Barriers to Uptake and Potential Intervention Targets” Diabetes Care Feb. 2017 40(2):181-187.
UK Prospective Diabetes Study (UKPDS) Group, “Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)” Lancet Sep. 12, 1998; 352(9131):837-853.
Vicente-Perez et al., “Repeat application of microneedles does not alter skin appearance or barrier function and causes no measurable disturbance of serum biomarkers of infection, inflammation or immunity in mice in vivo” European Journal of Pharmaceutics and Biopharmaceutics (2017) 117:400-407.
WaveForm Technologies Inc., “WaveForm Technologies Inc. Awarded CE Mark Approval for Their Continuous Glucose Monitoring System” Published on: Nov. 5, 2019, PRNewswire.com, Retrieved from Internet https://www.prnewswire.com/news-releases/waveform-technologies-inc-awarded-ce-mark-approval-for-their-continuous-glucose-monitoring-system-300952002. html, 1 page.
Windmiller, J.R et al. (2011). “Microneedle array-based carbon paste amperometric sensors and biosensors,” Analyst 136:1846-1851.
Yue et al., “Evaluation of a 12-Hour Sustained-Release Acetaminophen (Paracetamol) Formulation: A Randomized, 3-Way Crossover Pharmacokinetic and Safety Study in Healthy Volunteers” Clinical Pharmacology in Drug Development (2018) 7(1) 95-101.